A carbazole-based diaza[7]helicene, 2,12-dihexyl-2,12-diaza[7]helicene (1), was synthesized by a photochemical synthesis and its use as a deep-blue dopant emitter in an organic light-emitting diode (OLED) was examined. Compound 1 exhibited good solubility and excellent thermal stability with a high decomposition temperature (T(d)=372.1 °C) and a high glass-transition temperature (T(g), up to 203.0 °C). Single-crystal structural analysis of the crystalline clathrate (1)(2)⋅cyclohexane along with a theoretical investigation revealed a non-planar-fused structure of compound 1, which prevented the close-packing of molecules in the solid state and kept the molecule in a good amorphous state, which allowed the optimization of the properties of the OLED. A device with a structure of ITO/NPB (50 nm)/CBP:5 % 1 (30 nm)/BCP (20 nm)/Mg:Ag (100 nm)/Ag (50 nm) showed saturated blue light with Commission Internationale de L'Eclairage (CIE) coordinates of (0.15, 0.10); the maximum luminance efficiency and brightness were 0.22 cd A(-1) (0.09 Lm W(-1)) and 2365 cd m(-2), respectively. This new class of helicenes, based on carbazole frameworks, not only opens new possibilities for utilizing helicene derivatives in deep-blue-emitting OLEDs but may also have potential applications in many other fields, such as molecular recognition and organic nonlinear optical materials.

No abstract

EISAs (n = 20), showed a significant reduction of BPD (29.0 vs. 70.0%, p = 0.004) and PDA (29.0 vs. 65.0%, p = 0.011). In the subgroup analysis of blood gas, arterial oxygen saturation (SaO 2) value at 1 and 12 h and partial pressure of arterial oxygen (PaO 2) at 12 h were all higher in the EISA group compared to the MISA group. Conclusion : MISA had no clear benefit on the incidence of BPD, but it was related to a reduction in PDA. It is an appropriate therapy for spontaneous breathing in infants with extremely low birth weight and NRDS.

No abstract

This study provides an efficient analysis strategy to rapidly identify the triterpenoid saponins in Pulsatilla species even in traditional Chinese medicines.

The main purpose of this study was to investigate the potential of self-nanoemulsified drug delivery system (SNEDDS) to improve the oral bioavailability of tetrandrine (Tet). SNEDDS was developed by using rational blends of excipients with good solubilizing ability for Tet which was selected based on solubility studies. Further ternary phase diagram was constructed to determine the self-emulsifying region. The optimal formulation with the best self-nanoemulsified and solubilization ability consisted of 40% (w/w) oleic acid as oil, 15% (w/w) SPC and 30% (w/w) Cremophor RH-40 as surfactant, and 15% (w/w) PEG400 as cosurfactant. The average droplet size and zeta-potential of the optimal Tet SNEDDS were 19.75±0.37 nm and 1.87±0.26 mv, respectively. The dissolute rate of Tet SNEDDS in various dissolution media was remarkably faster than Tet commercial tablet. Moreover, in vivo pharmacokinetic study results show that significant increase (p≤ 0.05) in the peak concentration (Cmax) and the area under the curve (AUC) of Tet was observed after the oral administration of Tet SNEDDS and the absorption of Tet from SNEDDS resulted in approximately 2.33-fold increase in oral bioavailability compared with the commercial tablet. Our research suggests that the prepared Tet SNEDDS could be a good candidate for improved the dissolution and oral bioavailability of Tet.

No abstract

No abstract